Health Care & Life Sciences » Biotechnology | Zealand Pharma A/S

Zealand Pharma A/S | Balance Sheet

Fiscal year is January-December. All values DKK Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
310,561.00
538,273.00
440,199.00
336,947.00
663,829.00
1,159
Total Accounts Receivable
10,078.00
34,954.00
173,108.00
22,389.00
32,111.00
8
Other Current Assets
3,642.00
2,209.00
2,262.00
13,837.00
7,253.00
12
Total Current Assets
324,281.00
575,436.00
615,569.00
373,173.00
703,193.00
1,179
Net Property, Plant & Equipment
20,062.00
18,627.00
16,453.00
13,643.00
16,112.00
16
Total Investments and Advances
-
-
-
305,120.00
15,204.00
33
Other Assets
2,570.00
2,693.00
2,666.00
2,690.00
2,729.00
3
Total Assets
346,913.00
596,756.00
634,688.00
694,626.00
737,238.00
1,230
ST Debt & Current Portion LT Debt
-
5,000.00
-
3,365.00
2,748.00
Accounts Payable
13,376.00
18,487.00
21,676.00
19,739.00
29,428.00
Other Current Liabilities
17,396.00
53,271.00
47,830.00
64,450.00
43,608.00
Total Current Liabilities
30,772.00
76,758.00
69,506.00
87,554.00
75,784.00
Long-Term Debt
-
267,170.00
312,951.00
328,878.00
132,986.00
Total Liabilities
30,772.00
343,928.00
382,457.00
416,432.00
208,770.00
Common Equity (Total)
316,141.00
252,828.00
252,231.00
278,194.00
528,468.00
Total Shareholders' Equity
316,141.00
252,828.00
252,231.00
278,194.00
528,468.00
Total Equity
316,141.00
252,828.00
252,231.00
278,194.00
528,468.00
Liabilities & Shareholders' Equity
346,913.00
596,756.00
634,688.00
694,626.00
737,238.00

About Zealand Pharma A/S

View Profile
Address
Smedeland 36
Glostrup ZE 2600
Denmark
Employees -
Website http://www.zealandpharma.com
Updated 07/08/2019
Zealand Pharma A/S is a biotechnology company that engages in the discovery, design, and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark.